{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:43:11Z","timestamp":1791330191039,"version":"4.3.1"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T00:00:00Z","timestamp":1447718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141788","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T18:35:45Z","timestamp":1447785345000},"page":"e0141788","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":72,"title":["Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study"],"prefix":"10.1371","volume":"10","author":[{"given":"Maha M.","family":"Eissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham M.","family":"El-Moslemany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyaa A.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eglal I.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervat Z.","family":"El-Azzouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Labiba K.","family":"El-Khordagui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,17]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.biomaterials.2012.10.003","article-title":"Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug delivery","volume":"34","author":"W Du","year":"2013","journal-title":"Biomaterials"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4155\/fmc.11.92","article-title":"Target repurposing for neglected diseases","volume":"3","author":"MP Pollastri","year":"2011","journal-title":"Future Med Chem"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","article-title":"Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles","volume":"59","author":"AA Date","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpddr.2012.01.003","article-title":"Visceral leishmaniasis treatment: what do we have, what do we need and how to deliver it?","volume":"2","author":"LH Freitas-Junior","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/AAC.01315-13","article-title":"Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis","volume":"58","author":"CT Trinconi","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"TP Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1756-3305-4-73","article-title":"Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, <italic>Schistosoma haematobium<\/italic> and their snail hosts supported by Scanning Electron Microscopy","volume":"4","author":"MM Eissa","year":"2011","journal-title":"Parasit Vectors"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpara.2010.09.010","article-title":"Miltefosine, a promising novel agent for schistosomiasis mansoni","volume":"41","author":"MM Eissa","year":"2011","journal-title":"Int J Parasitol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","article-title":"Classification of orally adminis-tered drugs on the World Health Organization model list of essential medicinesaccording to the biopharmaceutics classification system","volume":"58","author":"M Lindenberg","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/dkt491","article-title":"The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)","volume":"69","author":"P Olliaro","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"41","key":"ref11","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.2174\/138161281941131219135458","article-title":"Nanotechnological strategies for the treatment of neglected diseases","volume":"19","author":"NM Khalil","year":"2013","journal-title":"Curr Pharm Des"},{"key":"ref12","unstructured":"De Oliveira CNF, De Oliveira RN, Frezza TF, Rehder VLG, Allegretti SM (2013) Tegument of as a Therapeutic Target. Chapter 8 in &quot;Parasitic Diseases\u2014Schistosomiasis&quot;, El Ridi, R, Ed. ISBN 978-953-51-0942-6."},{"key":"ref13","article-title":"Intestinal lymphatic delivery of praziquantel by solid lipid nanoparticles: Formulation Design, In Vitro and In Vivo Studies","author":"A Mishra","year":"2014","journal-title":"J Nanotech"},{"key":"ref14","first-page":"1","article-title":"Structured lipid carriers as a strategy to improve the in vitro schistosomiasis activity of praziquantel","volume":"14","author":"F Kolenyak-Santos","year":"2014","journal-title":"J Nanosci Nanotech"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF02535556","article-title":"Distribution and metabolism of hexadecylphosphocholine in mice","volume":"22","author":"A Breiser","year":"1987","journal-title":"Lipids"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1128\/AAC.01332-13","article-title":"Miltefosine increases lipid and protein dynamics in Leishmania amazonensis membranes at concentrations similar to those needed for cytotoxicity activity","volume":"58","author":"RA Moreira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","article-title":"Lipid nanocapsules: a new platform for nanomedicine","volume":"379","author":"NT Huynh","year":"2009","journal-title":"Int J Pharm"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2009.05.069","article-title":"The gastrointestinal stability of lipid nanocapsules","volume":"379","author":"E Roger","year":"2009","journal-title":"Int J Pharm"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2009.08.010","article-title":"Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis","volume":"140","author":"E Roger","year":"2009","journal-title":"J Control Release"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijpharm.2010.06.019","article-title":"Post-insertion into lipid nanocapsules (LNCs): From experimental aspects to mechanisms","volume":"396","author":"T Perrier","year":"2010","journal-title":"Int J Pharm"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jps.2600680138","article-title":"Direct spectorphotometric assay of quaternary ammonium compounds using bromthymol blue","volume":"68","author":"JB Lowry","year":"1979","journal-title":"J Pharm Sci"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0928-0987(99)00071-8","article-title":"Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect","volume":"9","author":"M Jumaa","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1017\/S0031182000086248","article-title":"Infection of laboratory hosts with cercaria of Schistosoma mansoni and the recovery of adult worms","volume":"55","author":"SR Smithers","year":"1965","journal-title":"Parasitol"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1128\/AAC.47.12.3853-3858.2003","article-title":"Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice","volume":"47","author":"S Botros","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1017\/S0031182000053920","article-title":"<italic>Schistosoma mansoni<\/italic>: structural damage and tegumental repair after in vivo treatment with praziquantel","volume":"94","author":"MK Shaw","year":"1987","journal-title":"Parasitol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","article-title":"To scale or not to scale: the principles of dose extrapolation","volume":"157","author":"V Sharma","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"1\u20132","key":"ref27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jchromb.2008.02.005","article-title":"Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography-tandem mass spectrometry","volume":"865","author":"TP Dorlo","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Y Zhang","year":"2010","journal-title":"Comput Methods Programs Biomed"},{"key":"ref29","first-page":"2941","article-title":"Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study","volume":"6","author":"A Ramadan","year":"2011","journal-title":"Int J Nanomed"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bcp.2005.11.008","article-title":"Modulation of intestinal barrier properties by miltefosine","volume":"71","author":"C Menez","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.biopha.2005.09.001","article-title":"A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines","volume":"60","author":"A Papagiannaros","year":"2006","journal-title":"Biomed Pharmacother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.canlet.2012.08.022","article-title":"Proapoptotic miltefosine nanovesicles show synergism with paclitaxel: Implications for glioblastoma multiforme therapy","volume":"334","author":"A Thakur","year":"2013","journal-title":"Cancer Letters"},{"key":"ref33","first-page":"142","article-title":"Interaction between hexadecylphosphocholine and cetyltrimethylammonium bromide","volume":"55","author":"ML Luk\u00e1\u010d","year":"2008","journal-title":"Acta Facult Pharm Univ Comenianae"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/187221108786241679","article-title":"Microemulsions: a novel approach to enhanced drug delivery","volume":"2","author":"S Talegaonkar","year":"2008","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cocis.2007.05.005","article-title":"Fatty acid vesicles","volume":"12","author":"K Morigaki","year":"2007","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"12086","DOI":"10.1021\/jp404135g","article-title":"Partitioning of oleic acid into phosphatidylcholine membranes is amplified by strain","volume":"117","author":"M Mally","year":"2013","journal-title":"J Phys Chem B"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.chemphyslip.2011.04.007","article-title":"Bilayer structures in dioctadecyldimethylammonium bromide\/oleic acid dispersions","volume":"164","author":"M Kepczynski","year":"2011","journal-title":"Chem Phys Lipids"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.colsurfa.2012.05.028","article-title":"Molecular structure\u2013surface property relationships for heterocyclic and dipropylamino derivatives of hexadecylphosphocholine and cetyltrimethylammonium bromide in NaBr and salt-free aqueous solutions","volume":"407","author":"M Pis\u00e1r\u010dik","year":"2012","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0005-2736(96)00090-9","article-title":"Preparation and properties of sterically stabilized hexadecylphosphocholine (miltefosine)-liposomes and influence of this modification on macrophage activation","volume":"1283","author":"R Zeisig","year":"1996","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"ref40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0168-3659(02)00258-4","article-title":"New lipid nanocapsules exhibit sustained release properties for amiodarone","volume":"84","author":"A Lamprecht","year":"2002","journal-title":"J Control Release"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/2191-219X-3-60","article-title":"Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT","volume":"3","author":"P Padmanabhan","year":"2013","journal-title":"EJNMMI Res"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.tiv.2013.06.010","article-title":"Effect of miltefosine on erythrocytes","volume":"27","author":"C Munoz","year":"2013","journal-title":"Toxicol In Vitro"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/minf.201300124","article-title":"Alkylphosphocholines as Promising Antitumor Agents: Exploring the Role of Structural Features on the Hemolytic Potential","volume":"33","author":"M Malta de S\u00e1","year":"2014","journal-title":"Mol Inf"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11094-010-0504-8","article-title":"Hemolytic properties of miltefosine in liposomes of various lipid compositions","volume":"44","author":"MV Zhukova","year":"2010","journal-title":"Pharm Chem J"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/17435390.2013.773465","article-title":"Surface functionalization affects the zeta potential, coronal stability and membranolytic activity of polymeric nanoparticles","volume":"8","author":"WS Cho","year":"2014","journal-title":"Nanotoxicology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1590\/S0037-86822008000400022","article-title":"Estudo comparative entre miltefosina oral e antimoniato de N-metil glucamina parenteral no tratamento da leishmaniose experimental causada por Leishmania (Leishmania) amazonensis","volume":"41","author":"AVD Filho","year":"2008","journal-title":"Rev Soc Bras Med Trop"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00436-011-2786-5","article-title":"Ultrastructural analysis of miltefosine-induced surface membrane damage in adult Schistosoma mansoni BH strain worms","volume":"110","author":"HG Bertao","year":"2012","journal-title":"Parasitol Res"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/0022-3859.911","article-title":"Miltefosine: great expectations against visceral leishmaniasis","volume":"49","author":"B More","year":"2003","journal-title":"J Postgrad Med"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1645\/GE-632R1.1","article-title":"Aspects of the cytological activity of edelfosine, miltefosine, and ilmofosine in Leishmania donovani","volume":"92","author":"S Azzouz","year":"2006","journal-title":"J Parasitol"},{"issue":"1","key":"ref50","first-page":"4291","article-title":"Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery","volume":"8","author":"AC Groo","year":"2013","journal-title":"Int J Nanomed"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2007.01.009","article-title":"Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsions","volume":"337","author":"SC Ara\u00fajo","year":"2007","journal-title":"Int J Pharmaceutics"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.biotechadv.2011.05.009","article-title":"Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice","volume":"30","author":"F Akhtar","year":"2012","journal-title":"Biotechnol Adv"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejps.2010.05.002","article-title":"Intestinal permeability enhancement of levothyroxine sodium by straight chain fatty acids studied in MDCK epithelial cell line","volume":"40","author":"D Pabla","year":"2010","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"ref54","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1128\/AAC.00173-10","article-title":"In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium","volume":"54","author":"R El Ridi","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4269\/ajtmh.14-0328","article-title":"Efficacy and safety of arachidonic acid for treatment of Schistosoma mansoni-infected children in Menoufiya, Egypt","volume":"91","author":"S Selim","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1039\/b907339f","article-title":"Fatty acid cationic surfactant vesicles: counter-ion self-encapsulation","volume":"5","author":"D Kopetzki","year":"2009","journal-title":"Soft Matter"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"H Sindermann","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"ref58","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s11095-013-1280-4","article-title":"Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules","volume":"31","author":"AC Groo","year":"2014","journal-title":"Pharm Res"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s11095-006-0022-2","article-title":"Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules","volume":"23","author":"S Peltier","year":"2006","journal-title":"Pharm Res"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biomaterials.2009.09.044","article-title":"Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting","volume":"31","author":"M Morille","year":"2010","journal-title":"Biomaterials"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2007.06.014","article-title":"In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel","volume":"344","author":"F Lacoeuille","year":"2007","journal-title":"Int J Pharm"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/S1413-86702008000100002","article-title":"Oral miltefosine treatment in children with visceral leishmaniasis: a brief review","volume":"12","author":"E Palumbo","year":"2008","journal-title":"Braz J Infect Dis"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2217\/nnm.14.124","article-title":"In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor","volume":"10","author":"AC Groo","year":"2015","journal-title":"Nanomedicine (Lond)"},{"issue":"2","key":"ref64","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/mp500527x","article-title":"Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles","volume":"12","author":"DR Serrano","year":"2015","journal-title":"Mol Pharm"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141788","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:44:23Z","timestamp":1588963463000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141788"}},"subtitle":[],"editor":[{"given":"Christianne","family":"Bandeira de Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,17]]},"references-count":64,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141788","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,17]]}}}